PostEra and Pfizer collaborate to promote machine learning for Drug Discovery


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ PostEra and Pfizer collaborate to promote machine learning for Drug Discovery
Through collaboration companies will leverage Pfizer's extensive data and experience with PostEra's technological resources to promote the science of generative chemistry

PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. in order to accelerate the discovery of small molecules of medicines, developing a platform technology based on generative chemistry.

PostEra's machine learning technology aims to accelerate the drug discovery process by developing new molecular structures with optimized potency and drug-like properties. PostEra's methods take chemical synthesis into account, as well as incorporate design hypotheses for medicinal chemicals.

Through collaboration, companies will leverage Pfizer's extensive data and experience with PostEra's technological resources to promote the science of generative chemistry and produce state-of-the-art, scalable models that could potentially be implemented in internal drug discovery efforts. -clinics.

PostEra will receive an advance payment and may receive additional payments as the project progresses. PostEra will also retain ownership rights to all algorithms developed during the collaboration.

"PostEra is pleased to work with Pfizer to address some of the key pain points in pre-clinical drug discovery," said Aaron Morris , CEO of PostEra. "As a team, we are proud to be part of this collaboration and we will be leveraging PostEra's many advances in machine learning to help Pfizer accelerate progress towards new therapies."

"We believe that our investments in machine learning technologies can help us accelerate the discovery of preclinical drugs. PostEra technology complements this effort, and we are excited to see the results of the collaboration," said Charlotte Allerton , Head of Design of Medicine from Pfizer.

Tags : #PostEra #LatestNewsonPostEra8thDec #Pfizer #LatestNewsonPfizer8thDec #LatestPharmaNews8thDec #LatestPharmaCollaboration8thDec

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026